Alyssa's GOSH family

Alyssa from Leicester started coming to GOSH when she was 13 years old. She had been diagnosed with with T-cell acute lymphoblastic leukaemia (T-ALL) the year before, but sadly all conventional therapies for her cancer, including chemotherapy and a bone marrow transplant, weren't working.

In May 2022, she became the first reported patient in the world to receive base-edited T-cells to treat her ‘incurable’ T cell leukaemia.

She was admitted to the Bone Marrow Transplant (BMT) Unit at GOSH, to receive genetically modified CAR T-cells that originally came from a healthy donor. These cells had been edited using new base-editing technology to allow them to hunt down and kill the cancerous T-cells without attacking each other.

Just 28 days later, she was in remission and went on the receive a second bone marrow transplant to restore her immune system. As part of her care and clinical trial, she lived on Robin Ward for four months, where she was cared for by staff from oncology, haematology, physiotherapy, the GOSH school, our play team and many more.

Scroll through the pictures below to see just some of the teams that have come together to support her and her family.

Relaxing at home with new dog, Holly © Family’s own

World-first treatment

In May 2022, Alyssa, became the first reported patient in the world to receive base-edited T-cells at GOSH, in collaboration with the UCL Great Ormond Street Institute of Child Health (UCL GOS ICH).

Read more about Alyssa's story